PortfoliosLab logo

C4 Therapeutics, Inc. (CCCC)

Equity · Currency in USD · Last updated Aug 13, 2022

Company Info

ISINUS12529R1077
CUSIP12529R107
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$12.30
Year Range$5.06 - $50.50
EMA (50)$10.11
EMA (200)$20.34
Average Volume$586.10K
Market Capitalization$601.64M

CCCCShare Price Chart


Chart placeholderClick Calculate to get results

CCCCPerformance

The chart shows the growth of $10,000 invested in C4 Therapeutics, Inc. in Oct 2020 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $6,474 for a total return of roughly -35.26%. All prices are adjusted for splits and dividends.


-80.00%-60.00%-40.00%-20.00%0.00%20.00%MarchAprilMayJuneJulyAugust
-45.84%
-2.76%
CCCC (C4 Therapeutics, Inc.)
Benchmark (^GSPC)

CCCCReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M26.93%12.08%
6M-48.25%-4.97%
YTD-61.80%-10.20%
1Y-65.75%-3.65%
5Y-20.84%13.51%
10Y-20.84%13.51%

CCCCMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-24.13%-8.19%8.16%-64.67%-15.29%3.86%27.85%27.59%
20219.03%18.83%-13.82%-10.52%11.63%2.41%14.01%-6.98%11.34%-0.58%-16.43%-13.25%
202030.26%38.18%-3.13%

CCCCSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current C4 Therapeutics, Inc. Sharpe ratio is -0.73. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.00MarchAprilMayJuneJulyAugust
-0.73
-0.20
CCCC (C4 Therapeutics, Inc.)
Benchmark (^GSPC)

CCCCDividend History


C4 Therapeutics, Inc. doesn't pay dividends

CCCCDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugust
-75.64%
-10.77%
CCCC (C4 Therapeutics, Inc.)
Benchmark (^GSPC)

CCCCWorst Drawdowns

The table below shows the maximum drawdowns of the C4 Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the C4 Therapeutics, Inc. is 89.98%, recorded on Jun 16, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-89.98%Sep 24, 2021184Jun 16, 2022
-34.65%Feb 11, 202147Apr 20, 202197Sep 7, 2021144
-19.07%Nov 30, 202010Dec 11, 20208Dec 23, 202018
-15.43%Oct 7, 20203Oct 9, 20207Oct 20, 202010
-13.74%Dec 24, 20206Jan 4, 20215Jan 11, 202111
-13.38%Jan 26, 20212Jan 27, 20214Feb 2, 20216
-9.71%Oct 22, 20208Nov 2, 202010Nov 16, 202018
-6.78%Jan 14, 20215Jan 21, 20211Jan 22, 20216
-2.8%Jan 12, 20211Jan 12, 20211Jan 13, 20212
-2.56%Sep 20, 20211Sep 20, 20211Sep 21, 20212

CCCCVolatility Chart

Current C4 Therapeutics, Inc. volatility is 94.58%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%100.00%200.00%300.00%400.00%MarchAprilMayJuneJulyAugust
94.58%
16.68%
CCCC (C4 Therapeutics, Inc.)
Benchmark (^GSPC)